Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized Gas MRI for Lung Transplant Rejection
NCT03697395Phase 2Active, not recruiting
- Sponsor
- University of Virginia
- Start
- Apr 2019
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 2, open-label trial of hyperpolarized xenon gas in chronic lung allograft dysfunction (CLAD), sponsored by University of Virginia. Primary endpoint: Successful collection of all samples as proposed at 24 months. Started Apr 2019; status: active, not recruiting.
02
Drugs
hyperpolarized xenon gas
03
Conditions
chronic lung allograft dysfunction (CLAD)
Beyond the preview
Go deeper on NCT03697395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03697395.